CHILELLI, NINO CRISTIANO
 Distribuzione geografica
Continente #
NA - Nord America 2.407
EU - Europa 276
AS - Asia 198
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.886
Nazione #
US - Stati Uniti d'America 2.406
CN - Cina 117
IT - Italia 100
FI - Finlandia 41
SG - Singapore 41
GB - Regno Unito 40
DE - Germania 27
SE - Svezia 26
VN - Vietnam 24
FR - Francia 12
IE - Irlanda 12
IN - India 11
UA - Ucraina 11
NL - Olanda 4
AU - Australia 2
IL - Israele 2
AR - Argentina 1
BO - Bolivia 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
JP - Giappone 1
PA - Panama 1
PK - Pakistan 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 2.886
Città #
Fairfield 451
Woodbridge 241
Chandler 237
Houston 226
Seattle 183
Ashburn 171
Ann Arbor 153
Cambridge 151
Wilmington 131
Princeton 42
Jacksonville 38
Medford 35
San Diego 33
Beijing 32
Des Moines 32
Roxbury 30
Singapore 29
Dong Ket 24
New York 19
Helsinki 17
Boardman 15
Nanjing 15
Castel Maggiore 12
Dublin 12
Padova 11
Nanchang 8
Jinan 7
Shenyang 7
Hebei 6
Vicenza 6
Ardea 4
Dearborn 4
Shanghai 4
Taizhou 4
Tianjin 4
Brendola 3
Changsha 3
Guangzhou 3
Hefei 3
Jiaxing 3
London 3
Milan 3
Carano 2
Guidizzolo 2
Haikou 2
Hangzhou 2
Hounslow 2
Hyderabad 2
Lviv 2
New Delhi 2
Noale 2
Ogden 2
Pune 2
Tappahannock 2
Tel Aviv 2
Treviso 2
Turin 2
Borås 1
Canberra 1
Cernusco sul Naviglio 1
Chicago 1
Cochabamba 1
Cordoba 1
Falls Church 1
Fuzhou 1
Genoa 1
Indiana 1
Islamabad 1
Kharkiv 1
Kilburn 1
Kunming 1
Lanzhou 1
Lappeenranta 1
Los Angeles 1
Marklohe 1
Ningbo 1
Osaka 1
Paese 1
Panama City 1
Redwood City 1
Rockville 1
San Francisco 1
Sandston 1
Shaoxing 1
Strasbourg 1
Sydney 1
Taiyuan 1
Verona 1
Washington 1
Xian 1
Zhengzhou 1
Ürümqi 1
Totale 2.480
Nome #
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 160
Long-term effect of pioglitazone vs glimepiride on lipoprotein oxidation in patients with type 2 diabetes: a prospective randomized study 121
Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes 115
AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view. 107
The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). 102
Genetic variability of the fructosamine 3-kinase gene in diabetic patients 101
Telemedicine in Pregnancy Complicated by DiabetesAdvances 100
Between reduction of glucose fluctuations and increased therapeutic adherence: an example of the benefits of vildagliptin in an elderly diabetic patient. 100
Pregnancy and foetal outcome after bariatric surgery: a review of recent studies. 98
Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. 97
The role of mass spectrometry in studies of glycation processes and diabetes management 96
Subclinical diastolic dysfunction in type 2 diabetic patients with and without carotid atherosclerosis: Relationship with glyco-oxidation, lipid-oxidation and antioxidant status. 95
The emerging role of telemedicine in managing glycemic control and psychobehavioral aspects of pregnancy complicated by diabetes. 94
Palpebral ptosis, fixed mydriasis and exophthalmos: An uncommon presentation of new diabetes mellitus 94
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial. 90
Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update 90
Screening with HbA1c identifies only one in two individuals with diagnosis of prediabetes at oral glucose tolerance test: findings in a real-world Caucasian population 89
Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance. 85
Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients 85
Glucose Fluctuations during Gestation: An Additional Tool for Monitoring Pregnancy Complicated by Diabetes. 83
Role of glycemic variability in gestational diabetes mellitus (GDM): still an uphill climb. 80
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 79
Focusing on potential sources of glucose fluctuations in type 1 and type 2 diabetes: Which kind of patient, what kind of glycemic variability and which confounding factors? 75
Autonomic testing: which value for each cardiovascular test? An observational study 75
Antioxidant capacity in patients with type 2 diabetes: A preliminary investigation on gender-specific differences in an Italian population 72
Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study 66
GLICAZIONE AVANZATA E OSSIDAZIONE LIPOPROTEICA: EFFETTI EXTRA-GLICEMICI DEL TRATTAMENTO CON PIOGLITAZONE IN PAZIENTI CON DIABETE TIPO 2 62
Lower urinary tract symptoms (LUTS) in males with type 2 diabetes recently treated with SGLT2 inhibitors—overlooked and overwhelming? A retrospective case series 58
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study 53
Better Ways to Cope with Increasingly Common Diseases: The Impact of Telemedicine on the Management of Pregnancy Complicated by DiabetesTelemedicine 52
In vitro chronic glycation induces AGEs accumulation reducing insulin stimulated glucose uptake and increasing GLP1R in adipocytes 43
Efficacia della dieta mediterranea con integrazione di riso rosso fermentato nel trattamento di pazienti dislipidemicicon e senza diabete di tipo 2 38
Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM 35
Telemedicine in Pregnancy Complicated by DiabetesAdvances in Telemedicine: Applications in Various Medical Disciplines and Geographical Regions 29
Ipo e iper-glicemia: stimolo infiammatorio per i monociti circolanti. 29
Trattamento dell’Iperglicemia Mild nel Soggetto pre-diabetico e nel Paziente con Diabete Tipo 2 Intollerante a Metformina:un nuovo spazio per la nutraceutica 27
Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study 18
Ruolo dei prodotti di glicazione avanzata nelle complicanze microvascolari del diabete di tipo 2: "attori protagonisti" nella memoria metabolica? 15
Advanced glycation end-products in microvascular complications of type 2 diabetes: Are they “major actors” in metabolic memory? 10
Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review 2
Totale 2.920
Categoria #
all - tutte 9.906
article - articoli 9.283
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 623
Totale 19.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020713 86 26 27 63 72 45 71 84 83 67 53 36
2020/2021439 18 30 11 40 19 29 15 22 71 69 57 58
2021/2022552 12 51 90 39 26 21 18 68 27 11 57 132
2022/2023429 64 63 15 57 64 51 0 35 59 0 13 8
2023/2024189 15 29 19 14 5 26 13 4 15 7 23 19
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 2.920